
Frederick G L Huetwell Professor of Cardiovascular Medicine
Professor of Internal Medicine
Professor of Surgery
Professor of Pharmacology
Professor of Molecular and Integrative Physiology
Medical School
[email protected]
Available to mentor
Yuqing E Chen

Professor
Dr. Chen is an expert in diabetes and cardiovascular disease. He cloned Exendin 4 (BYETTA), facilitating GLP1 drug development. He discovered the mechanisms of nitro-fatty acids, novel anti-inflammatory signaling molecules, currently in phase 2 clinical trials. Recently he embarked in successful integration of human genetic discoveries with translational research.
-
Center MemberMM-PKUHSC Joint Institute
-
Center MemberBiosciences Initiative
-
Center MemberCaswell Diabetes Institute
-
Center MemberSamuel and Jean Frankel Cardiovascular Center
-
Wang Z, Mu W, Zhong J, Xu R, Liu Y, Zhao G, Guo Y, Zhang J, Surakka I, Chen YE, Chang L. Journal of Clinical Investigation, 2025 Feb 3; 135 (3):Journal ArticleVascular smooth muscle cell PRDM16 regulates circadian variation in blood pressure
DOI:10.1172/JCI183409 PMID: 39625782 -
Jin T, Chen YE. Cardiovascular Drugs and Therapy, 2025 Feb 1; 39 (1): 9 - 12.Journal ArticleInternational Accolades for GLP-1 Research: Recognizing Pioneers in Diabetes and Obesity Treatment Across Five Prestigious Awards
DOI:10.1007/s10557-024-07630-9 PMID: 39470894 -
Sun Y, Zhang Y, Zhang J, Chen YE, Jin JP, Zhang K, Mou H, Liang X, Xu J. Cell and Bioscience, 2024 Dec 1; 14 (1):Journal ArticleXBP1-mediated transcriptional regulation of SLC5A1 in human epithelial cells in disease conditions
DOI:10.1186/s13578-024-01203-x -
Yang Y, Feng H, Tang Y, Wang Z, Qiu P, Huang X, Chang L, Zhang J, Chen YE, Mizrak D, Yang B. Science Translational Medicine, 2024 May 8; 16 (746):Journal ArticleBioengineered vascular grafts with a pathogenic TGFBR1 variant model aneurysm formation in vivo and reveal underlying collagen defects
DOI:10.1126/scitranslmed.adg6298 PMID: 38718134 -
Zhou L, Qiu X, Meng Z, Liu T, Chen Z, Zhang P, Kuang H, Pan T, Lu Y, Qi L, Olson DP, Xu XZS, Chen YE, Li S, Lin JD. Science Translational Medicine, 2024 Mar 13; 16 (738):Journal ArticleHepatic danger signaling triggers TREM2<sup>+</sup> macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
DOI:10.1126/scitranslmed.adk1866 PMID: 38478630 -
Ghrayeb A, Finney AC, Agranovich B, Peled D, Anand SK, McKinney MP, Sarji M, Yang D, Weissman N, Drucker S, Fernandes SI, Fernández-García J, Mahan K, Abassi Z, Tan L, Lorenzi PL, Traylor J, Zhang J, Abramovich I, Chen YE, Rom O, Mor I, Gottlieb E. Cell Metabolism, 2024 Jan 2; 36 (1): 116 - 129.e7.Journal ArticleSerine synthesis via reversed SHMT2 activity drives glycine depletion and acetaminophen hepatotoxicity in MASLD
DOI:10.1016/j.cmet.2023.12.013 PMID: 38171331 -
Liu H, Zhao Y, Zhao G, Deng Y, Chen YE, Zhang J. Cells, 2024 Jan 1; 13 (2):Journal ArticleSWI/SNF Complex in Vascular Smooth Muscle Cells and Its Implications in Cardiovascular Pathologies
DOI:10.3390/cells13020168 PMID: 38247859 -
Liang X, Hou X, Bouhamdan M, Sun Y, Song Z, Rajagopalan C, Jiang H, Wei HG, Song J, Yang D, Guo Y, Zhang Y, Mou H, Zhang J, Chen YE, Sun F, Jin JP, Zhang K, Xu J. JCI Insight, 2024 Jan 1; 9 (6):Journal ArticleSotagliflozin attenuates liver-associated disorders in cystic fibrosis rabbits
DOI:10.1172/jci.insight.165826 PMID: 38358827

Health Lab
Researchers have discovered a new molecular process that occurs when donor hearts are preserved in cold storage which contributes to failure after transplant, a study in both humans and animals shows. Fortunately, therapy that is typically prescribed for high blood pressure can target this process to reduce cold preservation associated with cardiac injury. This discovery has potential to improve the consistent function of donor hearts and extend the distance they can be safely transported in cold storage.

Health Lab
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.